Compare S H Kelkar & Co. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -6.22% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.24 times
- The company has been able to generate a Return on Equity (avg) of 9.04% signifying low profitability per unit of shareholders funds
Flat results in Jun 26
Falling Participation by Institutional Investors
Underperformed the market in the last 1 year
Stock DNA
Specialty Chemicals
INR 2,364 Cr (Small Cap)
50.00
44
0.60%
0.71
3.33%
1.71
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Feb-13-2026
Risk Adjusted Returns v/s 
Returns Beta
News

S H Kelkar & Company Ltd Technical Momentum Shifts Amid Mixed Market Signals
S H Kelkar & Company Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of technical indicators that suggest cautious optimism amid persistent challenges.
Read full news article
S H Kelkar & Company Ltd Technical Momentum Shifts Amid Mixed Market Signals
S H Kelkar & Company Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 1.03% to close at ₹166.30, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious investor sentiment amid broader market challenges.
Read full news article
S H Kelkar & Company Ltd is Rated Sell
S H Kelkar & Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
04-Aug-2026 | Source : BSEWe are enclosing herewith the transcript of the Conference Call for Investors and Analysts for Q1 FY27 results
Scrutinizers Report
01-Aug-2026 | Source : BSEVoting results and Scrutinizers Report-70th Annual General Meeting
Shareholder Meeting / Postal Ballot-Outcome of AGM
31-Jul-2026 | Source : BSEPlease find enclosed summary proceedings of the 70th Annual General Meeting of the Company
Corporate Actions 
No Upcoming Board Meetings
S H Kelkar & Company Ltd has declared 10% dividend, ex-date: 13 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
8.2954
Held by 4 Schemes (5.67%)
Held by 49 FIIs (5.92%)
Ramesh Vinayak Vaze Family Trust (ramesh Vaze, Prabha Vaze & Kedar Vaze-in The Capacity Of Trustee) (19.51%)
Firmenich Aromatics Production (india) Pvt Ltd (9.8%)
19.19%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 1.98% vs 11.27% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 2,354.05% vs -94.34% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024
Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.43% vs 13.36% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 330.23% vs -132.99% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 11.48% vs 15.35% in Mar 2025
YoY Growth in year ended Mar 2026 is -5.43% vs -40.17% in Mar 2025






